Erschienen in:
01.06.2014 | Urologic Oncology
Prognostic Significance of CD204-Positive Macrophages in Upper Urinary Tract Cancer
verfasst von:
Takashi Ichimura, MD, Teppei Morikawa, MD, PhD, Taketo Kawai, MD, PhD, Tohru Nakagawa, MD, PhD, Hirokazu Matsushita, MD, PhD, Kazuhiro Kakimi, MD, PhD, Haruki Kume, MD, PhD, Shumpei Ishikawa, MD, PhD, Yukio Homma, MD, PhD, Masashi Fukayama, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 6/2014
Einloggen, um Zugang zu erhalten
Abstract
Background
Evidence suggests that CD204-positive (CD204+) tumor-infiltrating macrophages are associated with aggressive behavior of various cancers; however, the clinical, pathological, and prognostic associations of tumor-infiltrating CD204+ macrophages in urothelial cancer have not been reported.
Methods
A tissue microarray was constructed from the centers and peripheries of 171 upper urinary tract cancers treated with nephroureterectomy. CD204 immunohistochemistry was performed. The density of CD204+ cells was calculated using image analysis software, and survival analyses were performed using the Kaplan–Meier method and multivariate Cox proportional hazards regression models.
Results
High CD204+ cell density at the centers and peripheries of tumors was significantly associated with several adverse prognostic factors, including sessile architecture, histological high-grade, presence of lymphovascular invasion, concomitant carcinoma in situ, higher tumor stage, and lymph node metastasis. High CD204+ cell density was significantly associated with shorter metastasis-free and cancer-specific survival (log-rank p < 0.001) and shorter metastasis-free survival in multivariate analysis.
Conclusions
A high density of tumor-infiltrating CD204+ macrophages was associated with aggressive behavior of upper urinary tract cancer. Our results suggest that a specific immune microenvironment may be associated with the biological behavior of urothelial cancer and that CD204 may serve as a novel prognostic biomarker for these tumors.